Synabs

SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds and complex antigens. Either as a custom service or as a catalog product, you can benefit from SYnAbs technologies to get access to unique monoclonal antibodies.

Do you know that one out of three times, IP immunization of mouse species with difficult antigens is a dead end?

To overtake these limitations, SYnAbs has developed the only proprietary rat and guinea pig myeloma cell lines, combined with unique immunization schemes to generate:

- your custom monoclonal antibodies against difficult and poor immunogenic antigens including but not limited to small molecules, antibiotics, toxins, peptides, steroids, neoepitopes, polysaccharides, epigenetic modifications thanks to our singular antigenic repertoire access, with a multi-species approach (mouse, rat and guinea pig) coupled with a multi-immunization technique.

https://www.synabs.be/rat-monoclonal-antibodies/

- an extensive catalog of off-the-shelf high-value monoclonal antibodies like anti-IgG4, anti-VHH, anti-CAR-T, isotypes and anti-isotypes antibodies, irrelevant and control antibodies (anti-DNP)...

https://www.synabs.be/our-antibody-products/

- an integrated service offer from the antigen synthesis, its coupling, animal immunization, the generation of stable clones, the manufacturing of several grams of mAbs and immunoaffinity and Quality Control assays (ELISA sandwich, competitive ELISA, affinity measurement, ADA test...).

https://www.synabs.be/custom-generation-of-high-affinity-mabs/

To be counted among its partners Dianova, Immunodiagnostic Systems, Unisensor, Coris Bioconcept, Artialis, VolitionRx, Univercells, Sanbio, CNRS, Thermo Fisher, Zentech, Sheffield University, Bio-Rad, Sapphire, Bio-X Diagnostics, Abcam, Dakewe, Neurogenic...